These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31444140)

  • 41. Comparison of effectiveness of carvedilol versus bisoprolol for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation.
    Katritsis DG; Panagiotakos DB; Karvouni E; Giazitzoglou E; Korovesis S; Paxinos G; Anagnostopoulos CE; Camm AJ
    Am J Cardiol; 2003 Nov; 92(9):1116-9. PubMed ID: 14583369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta-blockade in heart failure: selective versus nonselective agents.
    Metra M; Nodari S; Dei Cas L
    Am J Cardiovasc Drugs; 2001; 1(1):3-14. PubMed ID: 14728047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical, hemodynamic and neurohumoral effects of switching patients with chronic heart failure from not recommended -adrenoblockers to bisoprolol in ambulatory practice].
    Ageev FT; Zhubrina ES; Ovchinnikov AG; Seredenina EM
    Kardiologiia; 2010; 50(6):41-7. PubMed ID: 20659026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beta-blockade treatment in heart failure: the cardiac insufficiency bisoprolol study (CIBIS) project. CIBIS Committees and Investigators. Cardiac Insufficiency Bisoprolol Study.
    Lechat P
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S158-63. PubMed ID: 11534531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. beta-adrenergic receptor blockade in chronic heart failure.
    Bristow MR
    Circulation; 2000 Feb; 101(5):558-69. PubMed ID: 10662755
    [No Abstract]   [Full Text] [Related]  

  • 46. Unique effects of carvedilol on noradrenaline release in the human heart.
    Richardt G; Richardt D; Adler S; Kraatz E; Nötzold A; Kurz T
    Eur J Heart Fail; 2002 Mar; 4(2):147-9. PubMed ID: 11959042
    [No Abstract]   [Full Text] [Related]  

  • 47. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
    Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F
    Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies--CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study.
    Leizorovicz A; Lechat P; Cucherat M; Bugnard F
    Am Heart J; 2002 Feb; 143(2):301-7. PubMed ID: 11835035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-blocker benefit according to severity of heart failure.
    Bouzamondo A; Hulot JS; Sanchez P; Lechat P
    Eur J Heart Fail; 2003 Jun; 5(3):281-9. PubMed ID: 12798825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Beta blockers for therapy of chronic heart failure].
    Murakami T
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):248-54. PubMed ID: 15768588
    [No Abstract]   [Full Text] [Related]  

  • 51. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
    Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
    Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension.
    Taniguchi T; Ohtani T; Mizote I; Kanzaki M; Ichibori Y; Minamiguchi H; Asano Y; Sakata Y; Komuro I
    J Cardiol; 2013 Jun; 61(6):417-22. PubMed ID: 23548374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of bisoprolol on serum interleukin-6 and tumor necrosis factor-alpha level in patients with congestive heart failure].
    Tang FK; Hua N; Lu H; Xiao J; Tang XZ; Qi Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1177-9. PubMed ID: 19068205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does NT-proBNP remain a sensitive biomarker for chronic heart failure after administration of a beta-blocker?
    Li N; Li Y; Wang F; Jiang W; Huang J; Xu Z; Hua L; Hua C; Huang Y; Wu Y; Li F
    Clin Cardiol; 2007 Sep; 30(9):469-74. PubMed ID: 17803204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of beta-blockers on the adaptive immune system in chronic heart failure.
    Shaw SM; Coppinger T; Waywell C; Dunne L; Archer LD; Critchley WR; Yonan N; Fildes JE; Williams SG
    Cardiovasc Ther; 2009; 27(3):181-6. PubMed ID: 19689617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic Variation of Hepatic Enzymes Influence on β-Blocker Dose in Patients With Reduced Ejection Fraction Heart Failure.
    Ingram A; Valente M
    J Pharm Pract; 2020 Feb; 33(1):96-98. PubMed ID: 29916290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.
    Gao F; Chen J; Lopez BL; Christopher TA; Gu J; Lysko P; Ruffolo RR; Ohlstein EH; Ma XL; Yue TL
    Eur J Pharmacol; 2000 Oct; 406(1):109-16. PubMed ID: 11011041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Beneficial neurohormonal profiles of beta-blockades in chronic left heart failure].
    Wang F; Xu ZM; Wang L; Bian WY; Jia X; Duan B; Li W; Li YS
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):490-4. PubMed ID: 16080835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anemia Is Associated With Blunted Response to β-Blocker Therapy Using Carvedilol　- Insights From Japanese Chronic Heart Failure (J-CHF) Study.
    Nagatomo Y; Yoshikawa T; Okamoto H; Kitabatake A; Hori M;
    Circ J; 2018 Feb; 82(3):691-698. PubMed ID: 28883225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.